Allergan News | finanzen.ch

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Historisch

Analysen

02.02.12	Allergan kann Gewinn leicht verbessern (Aktiencheck)
02.02.11	Wall Street Update: US-Börsen zeigen sich zur Wochenmitte uneinheitlich (Aktiencheck)
01.11.10	Allergan weist Verlust aus, trifft Erwartungen (Aktiencheck)
10.03.10	BOTOX® (OnabotulinumtoxinA) Receives FDA Approval for Treatment of Upper Limb Spasticity in Adults (Businesswire)
01.02.10	Allergan, Inc. Announces FDA Approval of JUVÉDERM® XC Dermal Filler Formulated with Lidocaine (Businesswire)
25.09.09	Quintiles and Allergan Announce Co-Promotion for Sanctura XR® (Businesswire)
31.07.09	Allergan Reports Second Quarter 2009 Operating Results (Businesswire)
06.07.09	Allergan Announces Quarterly Conference Call (Businesswire)
01.05.09	Allergan Comments on Today’s Follow up by the U.S. Food and Drug Administration (FDA) to Its Early Communication, Concluding the Agency’s Safety Review of Botulinum Toxins (Businesswire)
30.04.09	Allergan Comments on FDA Requested Class Labeling for Botulinum Toxin Treatments in Connection with Approval of DYSPORT® (Businesswire)
04.02.09	Allergan Reports Fourth Quarter 2008 Operating Results and Announces Restructuring (Businesswire)
26.12.08	Allergan Announces U.S. Food and Drug Administration (FDA) Approval of LATISSE™ -- First and Only Treatment Approved by the FDA for Hypotrichosis of Eyelashes (Businesswire)
05.12.08	FDA Advisory Committee Unanimously Recommends Approval of LATISSE™ (Bimatoprost Solution 0.03%) as a Treatment for Hypotrichosis of Eyelashes (Businesswire)
29.10.08	Allergan Reports Third Quarter 2008 Operating Results (Businesswire)
29.10.08	Allergan, Inc. and Spectrum Pharmaceuticals, Inc. Announce Collaboration Agreement for Apaziquone (EOquin(R)) (Businesswire)
30.07.08	Allergan Reports Second Quarter 2008 Operating Results (Businesswire)
07.05.08	Allergan Reports First Quarter 2008 Operating Results (Businesswire)
04.03.08	Allergan Comments on the United States Department of Justice Subpoena for the Production of Documents Relating to Promotional Practices of BOTOX(R) for Therapeutic Uses (Businesswire)
25.01.08	Allergan, Inc. Responds to Public Citizen's Allegation Regarding a Fatality Following BOTOX(R) Cosmetic Treatment (Businesswire)
25.01.08	Allergan, Inc. Comments on BOTOX(R) (Botulinum Toxin Type A) Safety Profile (Businesswire)
31.10.07	Allergan, Inc. Receives FDA Approval for COMBIGAN(TM) (brimonidine tartrate/timolol maleate ophthalmic solution) 0.2%/0.5% (Businesswire)
01.08.07	Allergan Reports Second Quarter Operating Results (Businesswire)
26.06.07	Allergan Announces FDA Approval of Label Extensions for JUVEDERM(TM) Ultra and JUVEDERM(TM) Ultra Plus (Businesswire)
26.05.06	Allergan erhält von Europäischer Kommission gesamteuropäische Zulassung für GANFORT(R) (LUMIGAN(R)/Timolol-Kombination) (Businesswire)
25.05.06	Allergan Receives Pan European License for GANFORT(R) (LUMIGAN(R)/Timolol Combination) from European Commission (Businesswire)
27.03.06	Allergan erhält positive Bewertung für GANFORT(R) (LUMIGAN(R)/Timolol-Kombinationspräparat) in der Europäischen Union (Businesswire)
24.03.06	Allergan Receives Positive Opinion for GANFORT(R) (LUMIGAN(R)/Timolol Combination) in European Union (Businesswire)
07.02.06	Ausblick: Die Märkte am Dienstag (n/a)
21.12.05	Wall Street: Freundlicher Auftakt, Nike und FedEx im Blickpunkt (n/a)
21.12.05	Allergan und INAMED einigen sich auf Übernahme (n/a)
15.11.05	Wall Street Schluss: Schwacher Handel, Guidant-Übernahme erfreut Anleger (n/a)
24.10.05	NPS Pharmaceuticals to Promote Allergan's RESTASIS(R) to Rheumatologists in the United States (PR Newswire)
28.09.05	Allergan Receives Positive Opinions for COMBIGAN(TM) from 21 Countries in European Union (Businesswire)
12.05.05	Multimedia Available: Award-Winning TV Personality Joy Behar and Daugh (Businesswire)
27.04.05	Allergan Reports First Quarter Operating Results and Increases Full Ye (Businesswire)
05.04.05	Allergan Announces Quarterly Conference Call (Businesswire)
28.03.05	Allergan and Sanwa Kagaku Kenkyusho Co., Ltd. Sign Exclusive Licensing (Businesswire)
18.02.05	Multimedia Available: Botox Cosmetic -- Botulinum Toxin Type A -- Numb (Businesswire)
16.02.05	PediaMed Enters into Pediatric Co-Promotion Agreement with Allergan fo (Businesswire)
09.02.05	Allergan Comments on Diquafosol Results (Businesswire)
21.01.05	Allergan Announces Ruling in Product Classification Lawsuit (Businesswire)
18.01.05	Allergan Streamlines European Research and Development and Select Comm (Businesswire)
04.01.05	Allergan Launches PREVAGE-TM- Antioxidant Cream, the First and Only Cl (Businesswire)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Alcon	77.62	1.81 %	K V
CieFinRichemont	122.35	0.99 %	K V
Lonza Grp	531.00	0.84 %	K V
Zurich Insur Gr	553.00	0.18 %	K V
Novartis	91.93	0.00 %	K V
ABB	49.54	-0.84 %	K V
Swisscom	504.00	-0.98 %	K V
Sika	228.60	-1.12 %	K V
Holcim	88.42	-1.51 %	K V
UBS Group	27.76	-2.08 %	K V

mehr

26.11.24		Dow Jones aktuell: Dow Jones zum Handelsende in Grün
26.11.24		Börse New York: Dow Jones wenig verändert
26.11.24		Verluste in New York: Dow Jones legt den Rückwärtsgang ein
26.11.24		Börse Zürich: SMI letztendlich in Rot
26.11.24		S&P 500-Wert Pfizer-Aktie: So viel Verlust wäre bei einem Investment in Pfizer von vor einem Jahr angefallen
26.11.24		Dow Jones 30 Industrial-Papier Merck-Aktie: Wäre eine Merck-Investition von vor einem Jahr lukrativ gewesen?
26.11.24		Schwacher Handel in New York: Dow Jones zum Start mit Abgaben

26.11.24

Dow Jones aktuell: Dow Jones zum Handelsende in Grün

26.11.24

Börse New York: Dow Jones wenig verändert

26.11.24

Verluste in New York: Dow Jones legt den Rückwärtsgang ein

26.11.24

Börse Zürich: SMI letztendlich in Rot

26.11.24

S&P 500-Wert Pfizer-Aktie: So viel Verlust wäre bei einem Investment in Pfizer von vor einem Jahr angefallen

26.11.24

Dow Jones 30 Industrial-Papier Merck-Aktie: Wäre eine Merck-Investition von vor einem Jahr lukrativ gewesen?